A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAMF7 CAR-T Cells in Multiple Myeloma
NCT04499339
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
SLAMF7 CAR-T
Sponsor
Wuerzburg University Hospital
Collaborators
[object Object]